GNMX P&L Curve

Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF (GNMX) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $1.9M, listed on CBOE, carrying a beta of 2.27 to the broader market. GNMXtargets pure-play or the top 10 companies materially involved ingenomics and precision medicine, including those focused on gene sequencing, molecular diagnostics, gene editing and therapy, targeted treatments, and related healthcare technologies. public since 2026-05-06.

A profit/loss curve charts the theoretical gain or loss of an options position across a range of underlying prices. It helps traders visualize risk, identify breakeven points, and compare strategies before committing capital.

Exchange
CBOE
Sector
Financial Services
Industry
Asset Management
Market Cap
$1.9M
IPO Date
2026-05-06
Beta
2.27

As of Nov 13, 2026, the Corgi ETF Trust I - Corgi Genomics & Precision Medicine ETF spot price is $34.94; P&L scenarios can be constructed from the options chain. Payoff diagrams should be rebuilt from the live options chain; the preceding values are illustrative and assume a single at-the-money straddle for reference.